rs74625894
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_031157.4(HNRNPA1):c.133-17A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00402 in 1,606,530 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0029 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0041 ( 16 hom. )
Consequence
HNRNPA1
NM_031157.4 intron
NM_031157.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.929
Publications
0 publications found
Genes affected
HNRNPA1 (HGNC:5031): (heterogeneous nuclear ribonucleoprotein A1) This gene encodes a member of a family of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs), which are RNA-binding proteins that associate with pre-mRNAs in the nucleus and influence pre-mRNA processing, as well as other aspects of mRNA metabolism and transport. The protein encoded by this gene is one of the most abundant core proteins of hnRNP complexes and plays a key role in the regulation of alternative splicing. Mutations in this gene have been observed in individuals with amyotrophic lateral sclerosis 20. Multiple alternatively spliced transcript variants have been found. There are numerous pseudogenes of this gene distributed throughout the genome. [provided by RefSeq, Feb 2016]
HNRNPA1 Gene-Disease associations (from GenCC):
- amyotrophic lateral sclerosis type 20Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- inclusion body myopathy with Paget disease of bone and frontotemporal dementiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 12-54281778-A-G is Benign according to our data. Variant chr12-54281778-A-G is described in ClinVar as Benign. ClinVar VariationId is 261941.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00289 (440/152284) while in subpopulation AMR AF = 0.00811 (124/15292). AF 95% confidence interval is 0.00695. There are 1 homozygotes in GnomAd4. There are 200 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 440 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HNRNPA1 | NM_031157.4 | c.133-17A>G | intron_variant | Intron 2 of 10 | ENST00000340913.11 | NP_112420.1 | ||
| HNRNPA1 | NM_002136.4 | c.133-17A>G | intron_variant | Intron 2 of 9 | NP_002127.1 | |||
| HNRNPA1 | NR_135167.2 | n.215-17A>G | intron_variant | Intron 2 of 10 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HNRNPA1 | ENST00000340913.11 | c.133-17A>G | intron_variant | Intron 2 of 10 | 1 | NM_031157.4 | ENSP00000341826.7 |
Frequencies
GnomAD3 genomes AF: 0.00289 AC: 440AN: 152166Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
440
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00262 AC: 638AN: 243232 AF XY: 0.00260 show subpopulations
GnomAD2 exomes
AF:
AC:
638
AN:
243232
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00413 AC: 6013AN: 1454246Hom.: 16 Cov.: 32 AF XY: 0.00396 AC XY: 2867AN XY: 723350 show subpopulations
GnomAD4 exome
AF:
AC:
6013
AN:
1454246
Hom.:
Cov.:
32
AF XY:
AC XY:
2867
AN XY:
723350
show subpopulations
African (AFR)
AF:
AC:
22
AN:
33002
American (AMR)
AF:
AC:
198
AN:
42802
Ashkenazi Jewish (ASJ)
AF:
AC:
39
AN:
25836
East Asian (EAS)
AF:
AC:
0
AN:
39628
South Asian (SAS)
AF:
AC:
95
AN:
85462
European-Finnish (FIN)
AF:
AC:
12
AN:
53316
Middle Eastern (MID)
AF:
AC:
2
AN:
4734
European-Non Finnish (NFE)
AF:
AC:
5370
AN:
1109502
Other (OTH)
AF:
AC:
275
AN:
59964
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
260
521
781
1042
1302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00289 AC: 440AN: 152284Hom.: 1 Cov.: 32 AF XY: 0.00269 AC XY: 200AN XY: 74464 show subpopulations
GnomAD4 genome
AF:
AC:
440
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
200
AN XY:
74464
show subpopulations
African (AFR)
AF:
AC:
37
AN:
41554
American (AMR)
AF:
AC:
124
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
8
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
AC:
1
AN:
10620
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
264
AN:
68020
Other (OTH)
AF:
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
26
51
77
102
128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:1
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.